Anika Therapeutics, Inc. (ANIK)

Anika Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	62.37	72.87	86.33	94.39	95.82	157.46
Short-Term Investments	-	-	-	-	2.5	27.48
Cash & Short-Term Investments	62.37	72.87	86.33	94.39	98.32	184.94
Cash Growth	-11.72%	-15.59%	-8.54%	-4.00%	-46.84%	16.31%
Receivables	28.36	35.96	34.63	29.84	24.1	23.08
Inventory	39.63	46.39	39.77	36.01	46.21	22
Prepaid Expenses	5.75	8.1	8.83	8.29	8.75	4.29
Total Current Assets	136.11	163.31	169.55	168.53	177.38	234.31
Property, Plant & Equipment	71.78	74.97	78.98	68.56	73.23	73.65
Goodwill	7.66	7.57	7.34	7.78	8.41	7.69
Other Intangible Assets	3.08	4.63	74.6	82.38	91.16	7.59
Long-Term Deferred Tax Assets	1.47	1.49	1.45	-	-	-
Other Long-Term Assets	11.31	18.67	17.22	20.29	15.42	7.48
Total Assets	231.41	270.63	349.13	347.54	365.61	330.71
Accounts Payable	6.81	9.86	9.07	7.63	8.98	3.83
Accrued Expenses	16.31	15.92	15.96	16.13	13.21	11.3
Current Portion of Leases	2.29	2.13	2.07	1.71	1.59	1.14
Current Income Taxes Payable	0.08	1.24	0.81	-	-	-
Other Current Liabilities	-	1.9	-	4.32	13.09	-
Total Current Liabilities	25.49	31.06	27.91	29.8	36.87	16.28
Long-Term Leases	25.24	26.9	28.82	19.24	20.88	21.37
Long-Term Deferred Tax Liabilities	-	-	6.44	10.16	11.9	4.33
Other Long-Term Liabilities	0.81	0.4	0.4	1.26	23.56	0.36
Total Liabilities	51.54	58.37	63.57	60.45	93.21	42.33
Common Stock	0.15	0.15	0.15	0.14	0.14	0.14
Additional Paid-In Capital	91.89	90.01	81.14	67.08	55.36	48.71
Retained Earnings	93.53	128.05	210.72	225.58	221.44	245.43
Comprehensive Income & Other	-5.7	-5.94	-6.44	-5.72	-4.54	-5.9
Shareholders' Equity	179.86	212.27	285.56	287.09	272.4	288.38
Total Liabilities & Equity	231.41	270.63	349.13	347.54	365.61	330.71
Total Debt	27.53	29.04	30.89	20.95	22.46	22.51
Net Cash (Debt)	34.83	43.83	55.44	73.43	75.85	162.44
Net Cash Growth	-15.75%	-20.94%	-24.51%	-3.19%	-53.30%	2.15%
Net Cash Per Share	2.36	2.99	3.81	5.02	5.33	11.30
Filing Date Shares Outstanding	14.65	14.66	14.63	14.47	14.33	14.17
Total Common Shares Outstanding	14.69	14.66	14.63	14.44	14.33	14.31
Working Capital	110.61	132.25	141.63	138.73	140.52	218.03
Book Value Per Share	12.24	14.48	19.53	19.88	19.01	20.16
Tangible Book Value	169.13	200.07	203.63	196.92	172.83	273.1
Tangible Book Value Per Share	11.51	13.65	13.92	13.64	12.06	19.09
Machinery	-	54.16	54.53	51.19	50.81	44.94
Construction In Progress	-	4.73	5.02	1.38	0.43	0.56
Leasehold Improvements	-	34.98	34.92	34.61	34.06	33.8

Source: S&P Capital IQ. Standard template. Financial Sources.